<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:oboInOwl="http://www.geneontology.org/formats/oboInOwl#" xmlns:NCBITaxon="http://purl.obolibrary.org/obo/NCBITaxon#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:obo="http://purl.obolibrary.org/obo/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:ncbitaxon="http://purl.obolibrary.org/obo/ncbitaxon#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Feb. 2010, p. 620&#8211;626                                                                       Vol. 54, No. 2 <br /> 0066-4804/10/$12.00 doi:10.1128/AAC.01025-09 <br /> Copyright &#169; 2010, American Society Microbiology. All Rights Reserved. <br />  <br />  <br />  <br />         Newly Identified Antibacterial Compounds Are Topoisomerase <br />                       Poisons African Trypanosomes&#17188; <br />                                           Sonya C. Tang Theresa A. Shapiro* <br />                 Division Clinical Pharmacology, Department Medicine, The Johns Hopkins University School of <br />                                                Medicine, Baltimore, Maryland 21205 <br />                       Received 21 July 2009/Returned modification 24 September 2009/Accepted 6 December 2009 <br />  <br />             Human African trypanosomiasis, caused <span id='am-17' about='obo:NCBITaxon_5690' typeof='owl:Thing obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_33682 obo:NCBITaxon_5654 obo:NCBITaxon_2759 obo:NCBITaxon_5653'><span id='am-18' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-19' property="rdfs:label" content="Trypanosoma" datatype="xsd:string"></span><span id='am-20' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-21'  ></span>Trypanosoma</span> brucei protozoan parasite, fatal left <br />           untreated. Current therapies antiquated, need new pharmacologic agents T. <br />           brucei targets human ortholog. Trypanosomes single mitochondrion unique <br />           mitochondrial DNA, known kinetoplast DNA (kDNA), topologically complex network contains <br />           thousands interlocking circular DNAs, termed minicircles (&#11011;1 kb) maxicircles (&#11011;23 kb). Replication of <br />           kDNA depends topoisomerases, enzymes catalyze reactions change DNA topology. T. brucei an <br />           unusual type <span id='am-7' about='obo:NCBITaxon_360966' typeof='owl:Thing obo:NCBITaxon_9397 obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_32523 obo:NCBITaxon_131567 obo:NCBITaxon_117570 obo:NCBITaxon_32524 obo:NCBITaxon_32525 obo:NCBITaxon_89593 obo:NCBITaxon_7742 obo:NCBITaxon_117571 obo:NCBITaxon_33154 obo:NCBITaxon_1437010 obo:NCBITaxon_1338369 obo:NCBITaxon_40674 obo:NCBITaxon_8287 obo:NCBITaxon_9431 obo:NCBITaxon_314145 obo:NCBITaxon_2759 obo:NCBITaxon_6072 obo:NCBITaxon_33511 obo:NCBITaxon_33208 obo:NCBITaxon_7711 obo:NCBITaxon_30560 obo:NCBITaxon_7776 obo:NCBITaxon_9347'><span id='am-8' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-9'  ></span><span id='am-10' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-11' property="rdfs:label" content="Ia" datatype="xsd:string"></span>IA</span> topoisomerase dedicated kDNA metabolism. <span id='am-42' about='obo:NCBITaxon_169495' typeof='owl:Thing obo:NCBITaxon_33340 obo:NCBITaxon_33213 obo:NCBITaxon_169440 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_7147 obo:NCBITaxon_43733 obo:NCBITaxon_33154 obo:NCBITaxon_43738 obo:NCBITaxon_480117 obo:NCBITaxon_33317 obo:NCBITaxon_169449 obo:NCBITaxon_480118 obo:NCBITaxon_2759 obo:NCBITaxon_6072 obo:NCBITaxon_6960 obo:NCBITaxon_43750 obo:NCBITaxon_33208 obo:NCBITaxon_85512 obo:NCBITaxon_197562 obo:NCBITaxon_197563 obo:NCBITaxon_7203 obo:NCBITaxon_6656 obo:NCBITaxon_7496 obo:NCBITaxon_1206794 obo:NCBITaxon_88770 obo:NCBITaxon_33392 obo:NCBITaxon_169455 obo:NCBITaxon_50557 obo:NCBITaxon_43741'><span id='am-43' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-44' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-45' property="rdfs:label" content="This" datatype="xsd:string"></span><span id='am-46'  ></span>This</span> enzyme ortholog humans, <br />           RNA interference (RNAi) studies shown essential parasite survival, making ideal <br />           drug target. In large chemical library screen, compounds recently identified poisons bacterial <br />           topoisomerase IA. We compounds trypanocidal low micromolar range they <br />           promote formation linearized minicircles covalently bound protein 5&#11541; end, consistent the <br />           poisoning mitochondrial topoisomerase IA. Surprisingly, however, band depletion studies showed is <br />           topoisomerase IImt, topoisomerase IAmt, trapped. Both compounds planar aromatic <br />           polycyclic structures intercalate unwind DNA. These findings reinforce utility topoisom- <br />           erase IImt target development new drugs African sleeping sickness. <br />  <br />  <br />    Human African trypanosomiasis, known African                     intermediates, reattachment network progeny <br /> sleeping sickness, protozoal infection caused Trypano-              minicircles, retain nicks gaps circles have <br /> soma brucei fatal treatment (3). Parasites              replicated. Every step kDNA replication depends on <br /> transmitted humans tsetse fly, exclu-             function topoisomerases. These enzymes catalyze reac- <br /> sively sub-Saharan Africa limits geographic                 tions alter topological state DNA cleaving the <br /> distribution disease. Currently, estimated              phosphodiester backbone formation covalent <br /> 50,000 70,000 cases (25). Despite lethality sleeping              phosphotyrosine link, transferring segments DNA through <br /> sickness, drugs currently available treatment               break, ligating DNA (topoisomer- <br /> toxic require parenteral administration (10). In addi-             ases reviewed references 7, 9, 28). They classi- <br /> tion obstacles, resistance growing concern,             fied types, based number DNA strands <br /> and availability cost major problems population             cleaved: type I enzymes cleave strand type II en- <br /> affected. In light issues, new drugs African trypano-          zymes cleave strands reactions requiring ATP. Type I <br /> somiasis demand. The recently completed T. brucei                    enzymes classified A B subfamilies based <br /> genome sequence possible identification po-                 structural mechanistic differences. Topoisomerase IA <br /> tential drug targets essential trypanosomes and <br />                                                                             enzymes catalyze relaxation negatively supercoiled DNA <br /> have human ortholog (2). <br />                                                                             &#8220;enzyme bridging mechanism.&#65533;? After cleavage a <br />    Trypanosomes single mitochondrion unusual <br />                                                                             single strand, topoisomerase IA remains covalently bound to <br /> mitochondrial DNA, known kinetoplast DNA (kDNA). The <br />                                                                             5&#11032; end processively unwinds DNA. If enzyme <br /> kinetoplast massive topologically complex structure, <br />                                                                             acts preexisting nick, pass double <span id='am-29' about='obo:NCBITaxon_6534' typeof='owl:Thing obo:NCBITaxon_33208 obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_87862 obo:NCBITaxon_131567 obo:NCBITaxon_6533 obo:NCBITaxon_6527 obo:NCBITaxon_33154 obo:NCBITaxon_1206795 obo:NCBITaxon_216305 obo:NCBITaxon_216366 obo:NCBITaxon_216307 obo:NCBITaxon_977775 obo:NCBITaxon_6447 obo:NCBITaxon_33317 obo:NCBITaxon_6448 obo:NCBITaxon_2759 obo:NCBITaxon_120490 obo:NCBITaxon_6072'><span id='am-30' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-31'  ></span><span id='am-32' property="rdfs:label" content="Helix" datatype="xsd:string"></span><span id='am-33' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span>helix</span> <br /> comprised thousands interlocked &#11011;1-kb DNA minicircles <br />                                                                             resulting double-stranded break. The type II en- <br /> and dozen &#11011;23-kb maxicircles (structure replication <br />                                                                             zymes utilize 5&#11032;-end linkage catalysis, contrast <br /> of kDNA reviewed reference 16). This intricate network <br /> is striking contrast monomeric circular DNA                     IB topoisomerases, create covalent link 3&#11032; end <br /> molecule copies human mitochon-                    cleavage site. <br /> drion. Replication kDNA requires release individ-                    T. brucei catalytically active topoisomerases, and <br /> ual covalently closed minicircles network                   appear function exclusively mitochondrion: <br /> pool &#8220;free&#65533;? minicircles, DNA synthesis theta structure               topoisomerase IAmt topoisomerase IImt (15, 21). These mi- <br />                                                                             tochondrial enzymes especially attractive drug targets since <br />                                                                             essential according RNA interference (RNAi) and <br />   * Corresponding author. Mailing address: Johns Hopkins University         drug studies (21), depletion leads akinetoplasty <br /> School Medicine, 301 Hunterian Building, 725 North Wolfe Street, <br />                                                                             (the loss kDNA), turn results death (13). <br /> Baltimore, MD 21205. Phone: (410) 955-1888. Fax: (410) 955-2634. <br /> E-mail: tshapiro@jhmi.edu.                                                     Compounds target topoisomerases classified as <br />   &#17188; <br />     Published ahead print 14 December 2009.                           poisons nonpoisoning inhibitors (17). Poisons bind the <br />  <br />                                                                       620 <br />  VOL. 54, 2010                                                                         ANTITRYPANOSOMAL TOPOISOMERASE POISONS                                       621 <br />  <br />                                                                                     ogies, Inc.). Compounds 1895 0020 purchased ChemDiv (San <br />                                                                                     Diego, CA; catalog numbers 4333-1895 4711-0020, respectively), dissolved in <br />                                                                                     dimethyl sulfoxide (DMSO), aliquoted, stored &#11002;20&#176;C. <br />                                                                                        Cytotoxicity assay. Compounds 1895 0020 assayed antitrypano- <br />                                                                                     somal activity using acid phosphatase-based 96-well plate method (4). Briefly, <br />                                                                                     100 &#65533;?&#65533;l cells (2 &#11003; 105/ml) incubated 100 &#65533;?&#65533;l medium containing <br />                                                                                     solvent 2&#11003; serially diluted compound (20 24 h, 37&#176;C). Each concentration <br />                                                                                     assayed quadruplicate. Final DMSO concentrations did exceed 1%. <br />                                                                                     Lethality confirmed microscopic examination motility. Acid <span id='am-88' about='obo:NCBITaxon_128483' typeof='owl:Thing obo:NCBITaxon_33208 obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_33154 obo:NCBITaxon_216303 obo:NCBITaxon_37796 obo:NCBITaxon_1206795 obo:NCBITaxon_69555 obo:NCBITaxon_6447 obo:NCBITaxon_33317 obo:NCBITaxon_6448 obo:NCBITaxon_2759 obo:NCBITaxon_6479 obo:NCBITaxon_216293 obo:NCBITaxon_6072'><span id='am-89'  ></span><span id='am-90' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-91' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-92' property="rdfs:label" content="Phos" datatype="xsd:string"></span>phos</span>- <br />                                                                                     phatase activity surviving cells measured adding 20 &#65533;?&#65533;l buffer <br />                                                                                     containing 20 mg/ml p-nitrophenyl phosphate 1 M sodium acetate, pH 5.5, 1% <br />    FIG. 1. Molecular structure 1895 (A), N,N-dimethyl-2-                Triton X-100 (5 h, 37&#176;C). Absorbance measured 405 nm. Each compound <br /> (phenanthro[3,4-d][1,3]dioxol-5-yl)ethanamine, 0020 (B),               assayed times. Curve fitting 50% effective concentration (EC50) <br /> 2-(piperidin-1-ylmethyl)indeno[1,2,3-de]phthalazin-3-(2H)-one. Of in-               determinations obtained Emax model (12) DeltaGraph Pro 3.5. <br /> terest, 1895 contains methylenedioxy motif seen etoposide                 Based Chauvenet&#8217;s criterion (26), values (of 576 total) wells were <br /> and semisynthetic derivatives camptothecin, topo-                 identified outliers dropped analysis. <br /> isomerase poisons.                                                                     Free minicircle profiles. For concentration, 12 &#65533;?&#65533;l 10&#11003; compound was <br />                                                                                     added 1.2 &#11003; 107 cells 108 &#65533;?&#65533;l medium (30 min, 37&#176;C). Just lysis, a <br />                                                                                     portion taken Western blot analysis (see below). The remaining cells <br />                                                                                     lysed equal volume 10 mM Tris HCl, pH 8.0, 75 mM Na2-EDTA, <br /> Michaelis complex comprised DNA enzyme, forming                            1% SDS, 2 mg/ml proteinase K (2 h, 55&#176;C), treated with <br /> ternary DNA-protein-inhibitor &#8220;cleavable complex.&#65533;? In situ,                         100 &#65533;?&#65533;g/ml RNase A (30 min, 37&#176;C). Samples separated electrophoresis <br /> the presence poison prevents strand ligation, thus,                    1.5% agarose gels containing 89 mM Tris base, 89 mM boric acid, 2 mM <br />                                                                                     EDTA 1 &#65533;?&#65533;g/ml ethidium bromide (35 V, 24 h). DNA transferred a <br /> topoisomerase remains inert complex fixed                      Hybond XL membrane (GE Healthcare), washed 750 mM NaCl 75 mM <br /> DNA helix. Covalent adducts topoisomerase DNA                            sodium citrate, UV cross-linked (Stratagene UV Cross-linker 1800) mem- <br /> be forged rapid denaturation topoisomerase                           branes, hybridized Church-Gilbert solution 32P-labeled probe that <br /> detergents sodium dodecyl sulfate (SDS). Nonspecific                        recognizes 124-bp conserved minicircle sequence (overnight, 45&#176;C) (21). <br />                                                                                     Membranes exposed PhosphorImager plate scanned (Fuji <br /> inhibitors decrease topoisomerase activity pro- <br />                                                                                     BAS 2500 PhosphorImager) visualized Image Gauge version 3.45 (Fuji <br /> mote formation cleavable complexes. They include                         Photo Films Company). Unless indicated otherwise, Adobe Photoshop used <br /> agents deform DNA substrate, bind proteins high                       adjust contrast brightness only. <br /> affinity, compete binding active sites, DNA                          Exonuclease treatment. Trypanosomes treated 25.5 &#65533;?&#65533;M 1895 or <br /> and ATP analogs. In cell, stationary cleavable complexes                        63 &#65533;?&#65533;M 0020 (1 h, 37&#176;C) lysed digested proteinase K and <br />                                                                                     RNase A, described above. DNA extracted buffer-saturated phenol <br /> prove lethal replication machinery collides them,                         phenol-chloroform-isoamyl alcohol (25:24:1), followed back <br /> producing breaks DNA (11, 17). Therapeutically useful                        extraction ethanol precipitation. Samples redissolved 100 &#65533;?&#65533;l 10 <br /> topoisomerase-targeting agents poisons: fluoroquinolo-                      mM Tris HCl, pH 8.0, 1 mM Na2-EDTA; applied QiaAmp DNA microkit <br /> <span id='am-78' about='obo:NCBITaxon_203327' typeof='owl:Thing obo:NCBITaxon_186623 obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_186625 obo:NCBITaxon_117570 obo:NCBITaxon_7742 obo:NCBITaxon_89593 obo:NCBITaxon_117571 obo:NCBITaxon_123369 obo:NCBITaxon_33154 obo:NCBITaxon_123367 obo:NCBITaxon_123368 obo:NCBITaxon_123365 obo:NCBITaxon_123366 obo:NCBITaxon_8220 obo:NCBITaxon_1489872 obo:NCBITaxon_2759 obo:NCBITaxon_8219 obo:NCBITaxon_6072 obo:NCBITaxon_33511 obo:NCBITaxon_33208 obo:NCBITaxon_7711 obo:NCBITaxon_1489388 obo:NCBITaxon_1489875 obo:NCBITaxon_1489878 obo:NCBITaxon_1489341 obo:NCBITaxon_7776 obo:NCBITaxon_497223 obo:NCBITaxon_7898 obo:NCBITaxon_32443 obo:NCBITaxon_41665'><span id='am-79' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-80'  ></span><span id='am-81' property="rdfs:label" content="Nes" datatype="xsd:string"></span><span id='am-82' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span>nes</span> etoposide topoisomerase II poisons antibacte-                       (Qiagen) cleanup; eluted 30 &#65533;?&#65533;l distilled water; treated 10 U &#65533;?&#65533; <br /> rial antitumor therapy, respectively, camptothecin                     exonuclease buffer containing 67 mM <span id='am-12' about='obo:NCBITaxon_3846' typeof='owl:Thing obo:NCBITaxon_78536 obo:NCBITaxon_3814 obo:NCBITaxon_1 obo:NCBITaxon_72025 obo:NCBITaxon_131567 obo:NCBITaxon_3803 obo:NCBITaxon_3398 obo:NCBITaxon_1437183 obo:NCBITaxon_33090 obo:NCBITaxon_163735 obo:NCBITaxon_91827 obo:NCBITaxon_131221 obo:NCBITaxon_71240 obo:NCBITaxon_58024 obo:NCBITaxon_1437201 obo:NCBITaxon_58023 obo:NCBITaxon_91835 obo:NCBITaxon_2759 obo:NCBITaxon_35493 obo:NCBITaxon_71275 obo:NCBITaxon_3193'><span id='am-13' property="rdfs:label" content="Glycine" datatype="xsd:string"></span><span id='am-14'  ></span><span id='am-15' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-16' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span>glycine</span>-KOH, pH 9.4, 2.5 mM MgCl2, <br />                                                                                     50 &#65533;?&#65533;g/ml bovine serum albumin (BSA) 10 U exonuclease III buffer <br /> an antitumor agent poisons topoisomerase IB. For T.                            containing 10 mM Bis-Tris-propane-HCl, pH 7.0, 10 mM MgCl2, 1 mM dithio- <br /> brucei, poisons topoisomerase IAmt ideal                           threitol final volume 40 &#65533;?&#65533;l (30 min, 37&#176;C). HindIII-linearized pBluescript <br /> since enzyme human ortholog exclu-                         (80 ng) added treatment internal control. Minicircle DNA was <br /> sively mitochondrion kDNA (21).                                         separated visualized described above. <br />                                                                                        Western blot band depletion. The 8 &#11003; 106 cells reserved lysed with <br />    Recently, luciferase reporter detects accumu- <br />                                                                                     equal volume 117 mM Tris HCl, pH 6.8, 3.4% SDS, 10% glycerol, 0.2 M <br /> lation covalent DNA complexes recombinant Yersinia                          dithiothreitol, 0.004% bromophenol blue. Proteins separated SDS- <br /> pestis topoisomerase IA <span id='am-50' about='obo:NCBITaxon_562' typeof='owl:Thing obo:NCBITaxon_561 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_91347 obo:NCBITaxon_1224 obo:NCBITaxon_2 obo:NCBITaxon_543 obo:NCBITaxon_1236'><span id='am-51' property="rdfs:label" content="Escherichia coli" datatype="xsd:string"></span><span id='am-52' property="oboInOwl:hasAlternativeId" content="NCBITaxon:662101" datatype="xsd:string"></span><span id='am-53' property="oboInOwl:hasRelatedSynonym" content="Enterococcus coli" datatype="xsd:string"></span><span id='am-54' property="oboInOwl:hasDbXref" content="PMID:10319482" datatype="xsd:string"></span><span id='am-55' property="oboInOwl:hasExactSynonym" content="Escherichia/Shigella coli" datatype="xsd:string"></span><span id='am-56' property="oboInOwl:hasRelatedSynonym" content="Bacillus coli" datatype="xsd:string"></span><span id='am-57' property="oboInOwl:hasAlternativeId" content="NCBITaxon:662104" datatype="xsd:string"></span><span id='am-58' property="oboInOwl:hasDbXref" content="GC_ID:11" datatype="xsd:string"></span><span id='am-59'  ></span><span id='am-60' property="oboInOwl:hasRelatedSynonym" content="Eschericia coli" datatype="xsd:string"></span><span id='am-61' property="oboInOwl:hasRelatedSynonym" content="Bacterium coli commune" datatype="xsd:string"></span><span id='am-62' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-63' property="oboInOwl:hasRelatedSynonym" content="Escherchia coli" datatype="xsd:string"></span><span id='am-64' property="oboInOwl:hasRelatedSynonym" content="Bacterium coli" datatype="xsd:string"></span><span id='am-65' property="oboInOwl:hasRelatedSynonym" content="bacterium E3" datatype="xsd:string"></span>Escherichia coli</span> developed (8). The                  PAGE transferred polyvinyl difluoride membranes (Millipore). Blots <br /> system used high-throughput assay screen com-                       blocked 3% bovine serum albumin 25 mM Tris HCl, pH 7.4, 150 <br /> pounds poisoned Y. pestis topoisomerase IA. Three com-                         mM NaCl, 0.05% Tween 20, probed following primary then <br />                                                                                     secondary antibodies: anti-c-Myc (1:1,000; Santa Cruz Biotechnologies)&#8211;anti- <br /> pounds promote intracellular cleavable complex                        rabbit-horseradish peroxidase (anti-rabbit-HRP; 1:20,000; Santa Cruz Biotech- <br /> formation recombinant topoisomerase IA inhibit                        nologies) anti-T. brucei-topoisomerase IImt (1:5,000 [15])&#8211;anti-guinea pig- <br /> relaxation DNA isolated enzyme. These compounds                           HRP (1:40,000; Sigma). Loading control provided anti-human enolase <br /> also inhibited growth bacterial cells.                                       (1:200; Santa Cruz Biotechnologies)&#8211;anti-rabbit-HRP (1:30,000). Quantitation <br />                                                                                     Image J (1). <br />    Lead compounds 1 2 identified Y. pestis model <br />                                                                                        Precipitation topoisomerase-DNA complexes. The ability compounds <br /> (Fig. 1), referred 1895 0020, respectively,                     1895 0020 promote intracellular cleavable complex formation nuclear <br /> were tested T. brucei assess cytotoxic activity                      DNA determined potassium-SDS (KSDS) assay (5, 27). Trypanosomes <br /> ability poison topoisomerase IAmt. These compounds                          (107 cells ml) thymidine-free medium radiolabeled 333 &#65533;?&#65533;Ci/ml <br /> found trypanocidal micromolar concentrations,                         [3H]thymidine (20 Ci/mmol; Perkin-Elmer; 1 h, 37&#176;C), washed times, <br />                                                                                     resuspended 107 cells/ml, treated DMSO, 500 &#65533;?&#65533;M etoposide, 50 &#65533;?&#65533;M <br /> appear intercalate DNA, and, unexpectedly, pro-                        1895, 50 &#65533;?&#65533;M 0020 (30 min, 37&#176;C). Samples assayed triplicate. An equal <br /> mote linearization free minicircles poisoning intracellular                   volume lysis buffer (1.25% SDS, 5 mM EDTA, 0.4 mg/ml calf <span id='am-73' about='obo:NCBITaxon_49990' typeof='owl:Thing obo:NCBITaxon_78536 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_216706 obo:NCBITaxon_216718 obo:NCBITaxon_3398 obo:NCBITaxon_4136 obo:NCBITaxon_4143 obo:NCBITaxon_1437183 obo:NCBITaxon_33090 obo:NCBITaxon_91888 obo:NCBITaxon_91827 obo:NCBITaxon_131221 obo:NCBITaxon_71240 obo:NCBITaxon_58024 obo:NCBITaxon_1437201 obo:NCBITaxon_58023 obo:NCBITaxon_2759 obo:NCBITaxon_35493 obo:NCBITaxon_71274 obo:NCBITaxon_3193'><span id='am-74' property="rdfs:label" content="Thymus" datatype="xsd:string"></span><span id='am-75' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-76' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-77'  ></span>thymus</span> DNA) <br /> topoisomerase IImt.                                                                 added, lysates incubated (10 min, 65&#176;C). Covalent DNA-protein <br />                                                                                     complexes precipitated addition ice-cold 65 mM KCl washed <br />                                                                                     times 10 mM Tris HCl, pH 8.0, 100 mM KCl, 1 mM EDTA, 0.1 mg/ml <br />                         MATERIALS AND METHODS <br />                                                                                     calf thymus DNA, radioactivity counted liquid scintillation. Total <br />   All experiments performed bloodstream-form <span id='am-22' about='obo:NCBITaxon_5691' typeof='owl:Thing obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_39700 obo:NCBITaxon_33682 obo:NCBITaxon_5654 obo:NCBITaxon_5690 obo:NCBITaxon_2759 obo:NCBITaxon_5653'><span id='am-23' property="oboInOwl:hasRelatedSynonym" content="Trypanosoma (Trypanozoon) brucei" datatype="xsd:string"></span><span id='am-24' property="rdfs:label" content="Trypanosoma brucei" datatype="xsd:string"></span><span id='am-25' property="oboInOwl:hasRelatedSynonym" content="Trypanosoma brucei subgroup" datatype="xsd:string"></span><span id='am-26' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-27' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-28'  ></span>Trypanosoma brucei</span>           incorporation radioactivity control cells measured triplicate by <br /> brucei (MiTat 1.2 strain 427; doubling time, 6 8 h), containing c-Myc-tagged   aliquoting 5 &#11003; 105 untreated labeled cells glass filter paper precipitating <br /> topoisomerase IA allele (21), grown 37&#176;C HMI-9 containing 10% fetal           DNA 5% ice-cold trichloroacetic acid. To calculate percentage DNA <br /> bovine serum, 10% Serum Plus, 0.8 &#65533;?&#65533;g/ml G418 (Gibco BRL Life Technol-           trapped cleavable complexes, averaged counts minute detected in <br />  622      TANG AND SHAPIRO                                                                                        ANTIMICROB. AGENTS CHEMOTHER. <br />  <br />  <br />  <br />  <br />   FIG. 2. Killing activity T. brucei vitro 1895 (A) 0020 (B). For concentration tested (assayed quadruplicate), the <br /> coefficients variation 10%. <span id='am-83' about='obo:NCBITaxon_1369087' typeof='obo:NCBITaxon_37567 owl:Thing obo:NCBITaxon_33340 obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_85604 obo:NCBITaxon_104431 obo:NCBITaxon_33154 obo:NCBITaxon_37570 obo:NCBITaxon_41191 obo:NCBITaxon_33317 obo:NCBITaxon_2759 obo:NCBITaxon_6072 obo:NCBITaxon_6960 obo:NCBITaxon_33208 obo:NCBITaxon_41196 obo:NCBITaxon_197562 obo:NCBITaxon_85512 obo:NCBITaxon_197563 obo:NCBITaxon_95182 obo:NCBITaxon_41197 obo:NCBITaxon_6656 obo:NCBITaxon_7496 obo:NCBITaxon_7088 obo:NCBITaxon_1206794 obo:NCBITaxon_88770 obo:NCBITaxon_7100 obo:NCBITaxon_33392 obo:NCBITaxon_50557'><span id='am-84' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-85' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-86'  ></span><span id='am-87' property="rdfs:label" content="Data" datatype="xsd:string"></span>Data</span> fitted equation Emax model obtain EC50s; R2 values 0.99 graphs. <br />  <br />  <br />  <br /> KSDS precipitates divided averaged counts minute trichloro-   appears decrease linear forms, rebound <br /> acetic acid precipitates.                                                        120 &#65533;?&#65533;M. This wavering pattern observed repro- <br />    DNA unwinding. DNA unwinding 1895 0020 assayed described <br /> previously (24). In brief, 250 ng supercoiled pBluescript pBluescript <br />                                                                                  ducibly experiments. <br /> relaxed <span id='am-66' about='obo:NCBITaxon_561' typeof='owl:Thing obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_91347 obo:NCBITaxon_1224 obo:NCBITaxon_2 obo:NCBITaxon_543 obo:NCBITaxon_1236'><span id='am-67' property="oboInOwl:hasDbXref" content="PMID:19700542" datatype="xsd:string"></span><span id='am-68'  ></span><span id='am-69' property="oboInOwl:hasRelatedSynonym" content="Escherchia" datatype="xsd:string"></span><span id='am-70' property="rdfs:label" content="Escherichia" datatype="xsd:string"></span><span id='am-71' property="oboInOwl:hasDbXref" content="GC_ID:11" datatype="xsd:string"></span><span id='am-72' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span>Escherichia</span> coli topoisomerase IA treated various concen-       Linear forms expected product 1895 and <br /> trations 1895 0020 50 mM Tris HCl, pH 7.5, 50 mM NaCl, 5 mM        0020 poisoning topoisomerase IAmt. Since type I enzymes <br /> MgCl2, 1 pM <span id='am-1' about='obo:NCBITaxon_10245' typeof='owl:Thing obo:NCBITaxon_10240 obo:NCBITaxon_1 obo:NCBITaxon_35237 obo:NCBITaxon_10239 obo:NCBITaxon_10242 obo:NCBITaxon_10241'><span id='am-2' property="oboInOwl:hasRelatedSynonym" content="vaccinia virus VV" datatype="xsd:string"></span><span id='am-3' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-4'  ></span><span id='am-5' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-6' property="rdfs:label" content="Vaccinia virus" datatype="xsd:string"></span>vaccinia virus</span> topoisomerase IB (gift James         make single-stranded break, poisoning lead to <br /> Stivers) added (1 h, 37&#176;C). Reactions quenched addition 10&#11003; <br /> DNA loading dye containing 0.625% SDS, 0.125% xylene cyanol, 0.125% bro- <br />                                                                                  increase nicked, linearized, minicircles. However, the <br /> mophenol blue, 62.5% glycerol. DNA separated 1% agarose 89 mM          population nicked/gapped minicircles treated cells is <br /> Tris base, 89 mM boric acid, 2 mM EDTA visualized ethidium bromide        comparable controls (Fig. 3B 3C). Perhaps if <br /> fluorescence.                                                                    topoisomerase IAmt works preexisting nick a <br />                                                                                  minicircle molecules topoisomerase IAmt work <br />                                 RESULTS                                          adjacent opposite strands, linear forms could <br />                                                                                  generated treatment compounds 1895 0020. <br />    Trypanocidal activity vitro. Increasing concentrations of <br />                                                                                     Linearized minicircles protected exonuclease di- <br /> 1895 0020 tested bloodstream T. brucei to <br />                                                                                  gestion. To determine protein covalently bound <br /> assess killing activity (Fig. 2). In determinations, the <br />                                                                                  5&#11032; 3&#11032; end cleavage sites linear forms, <br /> EC50 1895 6.3 &#11006; 4.3 &#65533;?&#65533;M 0020 16.9 &#11006; 8.8 <br />                                                                                  minicircles extracted cells treated 1895 or <br /> &#65533;?&#65533;M. For perspective, potencies trypanosomes are <br />                                                                                  0020 subjected &#65533;?&#65533; exonuclease, degrades linear <br /> comparable known topoisomerase poisons (camp- <br />                                                                                  DNA 5&#11032; end, exonuclease III, degrades <br /> tothecin, 1.5 &#65533;?&#65533;M [4]; ciprofloxacin, 52 &#65533;?&#65533;M [18]) low <br />                                                                                  3&#11032; end (Fig. 4). Internal control linear pBluescript was <br /> compared clinically used agents trypanosomiasis <br />                                                                                  completely digested samples containing exonuclease, ver- <br /> (pentamidine, 14 nM [4]; berenil, 94 nM [4]), difluo- <br />                                                                                  ifying enzymatic activity (Fig. 4B). Minicircle linear forms from <br /> romethylornithine (&#11022;147 &#65533;?&#65533;M [29]). <br />    Compounds 1895 0020 promote minicircle lineariza-                         cells treated compound protected deg- <br /> tion. To determine antitrypanosomal activity related               radation &#65533;?&#65533; exonuclease exonuclease III, <br /> topoisomerase IAmt, free minicircle replication intermediates                    indicating DNA blocked protein 5&#11032; end <br /> from treated cells analyzed Southern hybridization (Fig.                 (Fig. 4A). This finding rules topoisomerase IB mecha- <br /> 3). When electrophoresed presence ethidium bro-                        nism (which requires 3&#11032;-phosphotyrosine link) most <br /> mide, free minicircles separated nicked/gapped daugh-                   consistent topoisomerase II, protein co- <br /> ter circles, linear forms, covalently closed template circles.               valently bound 5&#11032; end strands. However, type IA <br /> As expected, etoposide, known poison T. brucei topoisom-                    enzymes bind 5&#11032; end cleavage site. If the <br /> erase IImt (23), increased linearized minicircles concen-                   linear forms produced topoisomerase IAmt molecule <br /> tration-dependent fashion (Fig. 3A, left panel). These linear                    acted preexisting nick, single strand <br /> forms substantially reduced samples treated                      DNA protected digestion &#65533;?&#65533; exonuclease. <br /> proteinase K, consistent covalent linkage protein                  A new population minicircle DNA runs faster than <br /> (Fig. 3A, right panel).                                                          covalently closed circles does appear samples digested with <br />    Compounds 1895 0020 rise increase                      &#65533;?&#65533; exonuclease, present control sample <br /> protease-sensitive linear forms (Fig. 3B 3C). For 1895,                   treated &#65533;?&#65533; exonuclease. If topoisomerase IAmt mole- <br /> concentrations 0 40 &#65533;?&#65533;M, steady increase                   cules worked close proximity opposite strands, lin- <br /> in linear forms, 60 &#65533;?&#65533;M, population decreases                       earized forms strands protected 5&#11032; end could <br /> (Fig. 3B). Based proteinase K sensitivity, 80 100 &#65533;?&#65533;M,                  produced. <br /> the linear forms protein bound. For 0020, pattern                       Depletion free topoisomerase cell lysates. To deter- <br /> of protein-bound linear forms complicated (Fig. 3C).                     mitochondrial topoisomerase covalently linked <br /> In presence proteinase K, linear forms increase steadily                  linearized minicircles, lysates treated cells analyzed <br /> between 0 40 &#65533;?&#65533;M level 80 &#65533;?&#65533;M. At 100 &#65533;?&#65533;M                      immunoblotting. In method, topoisomerase enzyme <br />  VOL. 54, 2010                                                                  ANTITRYPANOSOMAL TOPOISOMERASE POISONS                             623 <br />  <br />  <br />  <br />  <br />    FIG. 3. Free minicircle profiles. T. brucei treated indicated lysed SDS buffer. Lysates digested (or not) proteinase <br /> K, indicated, DNA separated electrophoresis prior Southern blotting minicircle DNA. (A) Lanes 1 4, 0, 4, 20, 100 &#65533;?&#65533;M <br /> etoposide, respectively (5 &#11003; 106 cells/lane). (B) Lanes 1 7, 0, 10, 20, 40, 60, 80, 100 &#65533;?&#65533;M 1895, respectively (1.7 &#11003; 106 cells/lane). (C) Lanes <br /> 1 6, 0, 20, 40, 80, 100, 120 &#65533;?&#65533;M 0020, respectively (1.7 &#11003; 106 cells/lane). Samples treated 10 60 &#65533;?&#65533;M incomplete proteolysis and <br /> are shown. The position lanes blot switched present results increasing concentrations. N/G, nicked/gapped; L, <br /> linear; CC, covalently closed. <br />  <br />  <br />                                                                              covalently bound DNA unable enter gel matrix and <br />                                                                              free topoisomerase molecules detected (14). As ex- <br />                                                                              pected, etoposide treatment depletes topoisomerase IImt and <br />                                                                              effect topoisomerase IAmt (Fig. 5A 5B, left <br />                                                                              panels). Interestingly, cells treated 1895 0020, there <br />                                                                              decrease topoisomerase IAmt, indicating these <br />                                                                              compounds promote cleavable complex formation with <br />                                                                              enzyme trypanosomes (Fig. 5A, central right <span id='am-34' about='obo:NCBITaxon_9596' typeof='owl:Thing obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_9526 obo:NCBITaxon_9604 obo:NCBITaxon_32523 obo:NCBITaxon_131567 obo:NCBITaxon_32524 obo:NCBITaxon_117570 obo:NCBITaxon_32525 obo:NCBITaxon_89593 obo:NCBITaxon_7742 obo:NCBITaxon_117571 obo:NCBITaxon_33154 obo:NCBITaxon_1437010 obo:NCBITaxon_1338369 obo:NCBITaxon_40674 obo:NCBITaxon_8287 obo:NCBITaxon_2759 obo:NCBITaxon_314146 obo:NCBITaxon_6072 obo:NCBITaxon_33511 obo:NCBITaxon_33208 obo:NCBITaxon_7711 obo:NCBITaxon_314293 obo:NCBITaxon_314295 obo:NCBITaxon_376913 obo:NCBITaxon_7776 obo:NCBITaxon_9347 obo:NCBITaxon_207598 obo:NCBITaxon_9443'><span id='am-35'  ></span><span id='am-36' property="oboInOwl:hasExactSynonym" content="chimpanzees" datatype="xsd:string"></span><span id='am-37' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-38' property="oboInOwl:hasAlternativeId" content="NCBITaxon:445518" datatype="xsd:string"></span><span id='am-39' property="oboInOwl:hasAlternativeId" content="NCBITaxon:317028" datatype="xsd:string"></span><span id='am-40' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-41' property="rdfs:label" content="Pan" datatype="xsd:string"></span>pan</span>- <br />                                                                              els). However, lead significant decrease free <br />                                                                              topoisomerase IImt, indicating protein respon- <br />                                                                              sible minicircle linearization (Fig. 5B, central right <br />                                                                              panels). The depletion free topoisomerase IImt 1895 and <br />                                                                              0020 reproducibly obtained inde- <br />                                                                              pendent experiments, respectively. There effect the <br />                                                                              catalytic subunit topoisomerase IB (data shown), an <br />                                                                              enzyme acts nucleus mitochondrion of <br />                                                                              trypanosomes (5). <br />                                                                                 Nuclear topoisomerase II trapped cleavable com- <br />    FIG. 4. Exonuclease susceptibility minicircle DNA                 plexes. To assess possible effect nuclear topo- <br /> treated T. brucei. Cells treated drug, 25.5 &#65533;?&#65533;M 1895, or <br /> 63 &#65533;?&#65533;M 0020 indicated lysed SDS. Internal control                 isomerases, utilized KSDS assay. Since 95% DNA in <br /> HindIII-linearized pBluescript added sample prior             trypanosomes nuclear (6), assay monitors cleavable com- <br /> exonuclease treatment. (A) Southern blot minicircle DNA. Lanes            plex formation nucleus. In experiment, total <br /> 1, 4, 7, exonuclease. Lanes 2, 5, 8, &#65533;?&#65533; exonuclease. Lanes         incorporation [3H]thymidine 3.7 &#11003; 105 cpm/107 cells. In <br /> 3, 6, 9, exonuclease III. There 2.45 &#11003; 107 cells/lane. <br /> (B) Reaction internal control pBluescript DNA visualized by <br />                                                                              presence DMSO, 2.2% total DNA covalently <br /> ethidium bromide fluorescence prior DNA transfer minicircle           bound protein precipitated, attributable naturally <br /> hybridization.                                                               occurring topoisomerase catalytic complexes situ (Table 1). <br />  624       TANG AND SHAPIRO                                                                                          ANTIMICROB. AGENTS CHEMOTHER. <br />  <br />  <br />  <br />  <br />    FIG. 5. Western blots T. brucei proteins treatment indicated SDS lysis. (A) Free topoisomerase IAmt signals enolase <br /> controls. (Left) Lanes 1 3, 0, 4, 100 &#65533;?&#65533;M etoposide, respectively (1 &#11003; 106 cells/lane). (Center) Lanes 1 5, 0, 40, 60, 80, 100 &#65533;?&#65533;M 1895, <br /> respectively (8.33 &#11003; 105 cells/lane). (Right) Lanes 1 5, 0, 20, 60, 100, 120 &#65533;?&#65533;M 0020, respectively (8.33 &#11003; 105 cells/lane). In far-right panel <br /> these results quantitated correcting topoisomerase signal cognate enolase control normalizing treated samples <br /> to untreated controls. Etoposide, filled circles; 1895, filled squares; 0020, filled triangles. (B) Free topoisomerase IImt signals enolase controls; <br /> concentrations panel A. Membranes hybridized antibodies c-Myc (&#65533;?&#65533;-cMyc) visualize c-Myc-tagged topoisomerase IAmt, to <br /> topoisomerase IImt (&#65533;?&#65533;-IImt), enolase (&#65533;?&#65533;-en). In far-right panel, quantitation symbols given above. The quantitative data for <br /> all panels verified analysis independent investigator. <br />  <br />  <br />  <br /> As expected, etoposide increased signal four-                        prior electrophoresis. The binding intercalators as <br /> fold. In trypanosomes, trapping nuclear topoisomerase                        ethidium bromide causes DNA helix unwind form <br /> II apparent etoposide concentrations low 1 &#65533;?&#65533;M                       positive supertwists. In presence topoisomerase these <br /> is maximal &#11011;100 &#65533;?&#65533;M (data shown). For Table 1, 500                        relaxed equilibrium, topoisomerase and <br /> &#65533;?&#65533;M concentration utilized ensure robust positive                           intercalator subsequently removed, DNA hy- <br /> control. Interestingly, contrast etoposide, 1895                     pernegatively supercoiled. In absence added compound, <br /> and 0020 reduced cleavable complex formation nuclear                           vaccinia virus topoisomerase IB relaxes DNA substrates <br /> DNA, concentrations maximize linearization                           (Fig. 6A D, lanes 2). However, relaxation occurs the <br /> minicircles (Fig. 3 Table 1).                                                   presence ethidium bromide, isolated products hy- <br />    Compounds 1895 0020 unwind DNA. The polycyclic,                              pernegatively supercoiled (Fig. 6A D, lanes 3 4). This <br /> aromatic, planar structures 1895 0020 suggest                     unwinding effect seen, concentration-dependent <br /> compounds DNA intercalators. To assess possibil-                        fashion, 1895 0020 DNA substrates were <br /> ity, plasmid DNA incubated various concentrations                       negatively supercoiled relaxed (Fig. 6A D, lanes 5 10). <br /> 1895 0020 treated vaccinia virus topoisomerase IB, <br />                                                                                                             DISCUSSION <br />  <br />           TABLE 1. In situ formation topoisomerase-DNA                              With discovery essential mitochondrial topoisom- <br />                         cleavable complexes                                         erase IAmt T. brucei ortholog humans (21), it <br />                                               Cleavable complexes                   great study effects African trypano- <br />       Compounda <br />         (&#65533;?&#65533;M)                                                                        somes newly described antibacterial topoisomerase IA poi- <br />                                 % total DNAb                 Ratio DMSO <br />                                                                                     sons (8). Two compounds trypanocidal activity at <br /> DMSO                               2.2 &#11006; 0.05                         1.0           low micromolar concentrations. Furthermore, promoted <br /> Etoposide (500)                    9.0 &#11006; 0.81                         4.2           formation covalent protein adducts minicircle <br /> 1895 (50)                          1.9 &#11006; 0.09                         0.86          DNA, expected topoisomerase poisons oper- <br /> 0020 (50)                          1.7 &#11006; 0.13                         0.79 <br />                                                                                     ating mitochondrion trypanosomes. Protein at- <br />   a <br />     Each compound assayed triplicate.                                        tached 5&#11032; end minicircle DNA, consistent poi- <br />   b <br />     KSDS-precipitable radioactivity treated cells, percentage trichlo- <br /> roacetic acid-precipitable radioactivity untreated cells. Values means &#11006;     soning type IA enzyme. However, band depletion studies <br /> standard deviations.                                                                unexpectedly revealed enzyme captured the <br />  VOL. 54, 2010                                                              ANTITRYPANOSOMAL TOPOISOMERASE POISONS                                     625 <br />  <br />  <br />                                                                           tween chromosomal DNA minicircle DNA. It pos- <br />                                                                           sible compounds selectively concentrated the <br />                                                                           mitochondrion. <br />                                                                              Ability intercalate DNA explain varia- <br />                                                                           tion seen reproducibly accumulation linearized <br />                                                                           minicircles function concentration 1895 0020 (Fig. <br />                                                                           3B 3C). Intercalators insert DNA bases and <br />                                                                           unwind DNA mixed effects topoisomerases. <br />                                                                           Some intercalators inhibit topoisomerases poison- <br />                                                                           ing them, seen 4&#11032;-(9-acridinylamino)-methanesul- <br />                                                                           fon-o-anisidide (o-AMSA). Others, closely re- <br />                                                                           lated isomer m-AMSA, poison topoisomerase II, promote the <br />                                                                           formation double-stranded breaks, clinically useful <br />                                                                           antitumor agents (17, 19, 20). 2-Methyl-9-hydroxyellipticinium <br />                                                                           (2-Me-9-OH-E&#11001;), intercalator, effect similar to <br />                                                                           observe 1895 0020: low concentrations stim- <br />                                                                           ulate cleavable complex formation topoisomerase II, at <br />                                                                           higher concentrations trapping topoisomerase II re- <br />                                                                           duced (19, 20). These effects result distortion the <br />                                                                           substrate DNA induced strong intercalators present high <br />                                                                           ratios. The intercalation effect account a <br />                                                                           decrease linearization minicircles high concentrations <br />                                                                           reduction SOS response seen high <br />                                                                           concentrations 1895 used Y. pestis model (8). In <br />                                                                           keeping intercalation effect, unwinding assay <br />    FIG. 6. DNA unwinding assay. Lanes 1 4, supercoiled relaxed      0020 appears stronger intercalator 1895, consistent <br /> plasmid DNA (lanes 1) treated topoisomerase IB (lanes      greater inhibition cleavable complex formation with <br /> 2) topoisomerase IB presence 1.0 2.5 &#65533;?&#65533;g/ml <br /> ethidium bromide (lanes 3 4, respectively). Lanes 5 10, topo-      nuclear DNA (Table 1). <br /> isomerase IB treatment presence 500, 250, 125, 67.5, 33.8,      Compounds 1895 0020 poison mitochondrial <br /> 16.9 &#65533;?&#65533;M 1895, respectively (A B), 310, 155, 77.5, 38.8, 19.4,   type IA topoisomerase T. brucei, despite ability to <br /> 9.70 &#65533;?&#65533;M 0020, respectively (C D). There 100 ng plasmid            poison cognate enzyme bacteria. Instead, com- <br /> DNA/lane. EtBr, ethidium bromide; IB, vaccinia virus topoisomerase <br /> IB; sc DNA, supercoiled pBluescript plasmid substrate; DNA, re- <br />                                                                           pounds act mitochondrial, nuclear, topo- <br /> laxed pBluescript plasmid substrate.                                      isomerase II trypanosomes. Though unexpected, find- <br />                                                                           ings corroborate mitochondrial topoisomerase II a <br />                                                                           suitable target development much-needed new an- <br />                                                                           titrypanosomal drugs. <br /> trypanosome&#8217;s mitochondrial type II, type IA, topoisom- <br /> erase. Trapping mitochondrial type II enzyme                                          ACKNOWLEDGMENTS <br /> consistent protection 5&#11032; end minicircle DNA, and <br />                                                                              This work supported NIH R01AI028855, National Insti- <br /> it provides satisfying explanation formation pro-            tutes Health Medical Scientist Training Grant T32GM07309, and <br /> tein-bound linearized, nicked, minicircles               PhRMA Foundation&#8217;s Paul Calabresi Medical Student Research <br /> SDS lysis treated cells. Interestingly, T. brucei         Fellowship. The work received Excellence Medical Student <br /> a second type II topoisomerase operates nucleus,              Research award Johns Hopkins University School Medi- <br /> this enzyme poisoned 1895 0020 shown              cine. <br />                                                                              We thank Rahul Bakshi Jane Scocca assistance in <br /> KSDS assay.                                                               methodology, helpful discussions, suggestions manuscript. <br />    In trypanosomes, selective poisoning mitochondrial,             We grateful Paul Englund Robert Jensen sugges- <br /> but nuclear, topoisomerase II seen previously              tions, James Stivers providing vaccinia virus topoisomerase IB, and <br /> number structurally unrelated DNA-binding antitrypanoso-               Jeannette Fanning administrative support. <br /> mal drugs (22). This finding contrast seen with <br />                                                                                                           REFERENCES <br /> etoposide, does bind directly DNA traps both <br />                                                                            1. Abramoff, M. D., P. J. Magelhaes, S. J. Ram. 2004. Image processing <br /> nuclear mitochondrial topoisomerase II (23). The planar                   Image J. Biophotonics Int. 11:36&#8211;42. <br /> aromatic structure 1895 0020 suggested              2. Aguero, F., B. Al-Lazikani, M. Aslett, M. Berriman, F. S. Buckner, R. K. <br /> be acting intercalators T. brucei lead                   Campbell, S. Carmona, I. M. Carruthers, A. W. Chan, F. Chen, G. J. <br />                                                                               Crowther, M. A. Doyle, C. Hertz-Fowler, A. L. Hopkins, G. McAllister, S. <br /> differential poisoning mitochondrion nucleus. DNA                  Nwaka, J. P. Overington, A. Pain, G. V. Paolini, U. Pieper, S. A. Ralph, A. <br /> unwinding assays confirmed 1895 0020 DNA                     Riechers, D. S. Roos, A. Sali, D. Shanmugam, T. Suzuki, W. C. Van Voorhis, <br />                                                                               C. L. Verlinde. 2008. Genomic-scale prioritization drug targets: the <br /> intercalators. The exact basis selective poisoning mito-               TDR Targets database. Nat. Rev. Drug Discov. 7:900&#8211;907. <br /> chondrial nuclear type II topoisomerases DNA-                   3. Barrett, M. P., R. J. Burchmore, A. Stich, J. O. Lazzari, A. C. Frasch, J. J. <br /> binding agents unknown, relate intrinsic dif-                Cazzulo, S. Krishna. 2003. The trypanosomiases. Lancet 362:1469&#8211;1480. <br />                                                                            4. Bodley, A. L., M. W. McGarry, T. A. Shapiro. 1995. Drug cytotoxicity <br /> ferences enzymes, phylogenetically quite                 assay African trypanosomes Leishmania <span id='am-47' about='obo:NCBITaxon_species' typeof='owl:Thing NCBITaxon:_taxonomic_rank'><span id='am-48' property="rdfs:label" content="species" datatype="xsd:string"></span><span id='am-49' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span>species</span>. J. Infect. Dis. 172: <br /> distinct (15), marked structural differences be-                1157&#8211;1159. <br />  626       TANG AND SHAPIRO                                                                                                  ANTIMICROB. AGENTS CHEMOTHER. <br />  <br />  5. Bodley, A. L., T. A. Shap <br /> </body></html>